Women with CIN2− in the vaccinated group aged 18–24 years showed a reduction in the prevalence of HR HPV (26.2%) in the vaccine era, although the difference did not reach statistical significance.
← all excerpts
Reduction in HPV 16/18 prevalence among young women following HPV vaccine introduction in a highly vaccinated district, Japan, 2008-2017.
1
—
—